Nonsense Tx
Biotechnology Research
3 employees
- Employees
- 3
- Contacts
- 1
- Emails
- 1
- Phones
- 1
Nonsense Tx Overview
- Website
- www.nonsensetx.com
- Industry
- Biotechnology Research
- Employees
- 3
- Founded
- 2023
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Nonsense Tx
Nonsense mutations cause about 10-12% of cases across over 10,000 rare diseases, impacting roughly 40 million people. These mutations often lead to the most severe disease outcomes. At Nonsense Tx, we focus on developing small-molecule therapies to boost collagen 7 production for Dystrophic EB patients. 35% of RDEB patients have at least one nonsense mutation. Early lab results using primary patient cells—tested with a leading expert on nonsense mutations in EB—have shown very promising outcomes
Nonsense Tx Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
- Phone contacts
- 1
- 33.3% coverage
Nonsense Tx Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Lev Osherovich | Scientist, Company Builder, Investor |
View
|
|
| Alex Hersham | Founder of Nonsense Tx & Zencargo | London, England, United Kingdom |
Email
Phone
|
| Roy Shiny | Unemployed at Nonsense Tx |
View
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Compare Similar Companies to Nonsense Tx
Zencargo
Transportation, Logistics, Supply Chain And Storage
Huckletree
Hospitality
Termeer Institute
Biotechnology Research
General Projects
Real Estate
Arpelos Biosciences
Biotechnology Research
Navega Therapeutics
Biotechnology Research
Momentum Therapeutics
Biotechnology Research
DUB Therapeutics
Biotechnology Research
ABE (Accelerating Breakthroughs in EB)
Biotechnology Research
HydroGene Therapeutics
Biotechnology Research